Stocks Overview

LAST PRICE
2.7400
TODAY'S CHANGE (%)
Trending Down-0.0700 (-2.4911%)

Bid / Lots
2.6300/ 1
Ask / Lots
3.0000/ 1
Open / Previous Close
2.8100 / 2.8100
Day Range
Low 2.7300
High 2.8100
52 Week Range
Low 0.9201
High 4.3600
Volume
562,550
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Thursday's close: 2.82
Time	Volume	MREO
09:32 ET	1487	2.805
09:36 ET	3804	2.77
09:38 ET	886	2.78
09:39 ET	1100	2.775
09:41 ET	486	2.775
09:43 ET	2534	2.78
09:45 ET	3200	2.78
09:48 ET	490	2.78
09:50 ET	10252	2.755
09:52 ET	10051	2.78
09:54 ET	3699	2.79
09:56 ET	25386	2.774
09:57 ET	1152	2.79
09:59 ET	200	2.7988
10:01 ET	200	2.78
10:06 ET	1600	2.788
10:08 ET	3965	2.7999
10:10 ET	1100	2.7982
10:12 ET	100	2.7999
10:14 ET	3456	2.8099
10:15 ET	6800	2.775
10:19 ET	100	2.775
10:21 ET	5312	2.76
10:24 ET	2594	2.755
10:26 ET	8800	2.76
10:28 ET	600	2.765
10:30 ET	2483	2.775
10:32 ET	3300	2.78
10:33 ET	8700	2.795
10:35 ET	1743	2.81
10:37 ET	1800	2.8
10:39 ET	2097	2.79
10:42 ET	100	2.7887
10:44 ET	1335	2.775
10:46 ET	2456	2.77
10:48 ET	2532	2.78
10:50 ET	12200	2.795
10:51 ET	400	2.795
10:55 ET	200	2.795
10:57 ET	500	2.795
11:00 ET	100	2.795
11:02 ET	1324	2.81
11:04 ET	250	2.802
11:06 ET	100	2.805
11:08 ET	4365	2.8
11:09 ET	100	2.795
11:11 ET	2384	2.775
11:15 ET	500	2.77
11:18 ET	100	2.77
11:20 ET	300	2.775
11:22 ET	6681	2.765
11:24 ET	100	2.765
11:27 ET	450	2.76
11:29 ET	100	2.76
11:33 ET	1828	2.76
11:38 ET	500	2.765
11:40 ET	200	2.76
11:42 ET	200	2.765
11:44 ET	100	2.765
11:45 ET	300	2.76
11:49 ET	200	2.76
11:51 ET	100	2.76
11:54 ET	200	2.76
11:56 ET	100	2.76
11:58 ET	100	2.76
12:00 ET	815	2.765
12:02 ET	14747	2.76
12:03 ET	6378	2.775
12:05 ET	800	2.775
12:07 ET	8458	2.77
12:09 ET	5069	2.7611
12:14 ET	1000	2.76
12:16 ET	200	2.76
12:18 ET	300	2.76
12:20 ET	100	2.76
12:23 ET	300	2.76
12:25 ET	209	2.76
12:27 ET	1802	2.755
12:30 ET	300	2.755
12:32 ET	100	2.755
12:34 ET	462	2.755
12:36 ET	100	2.75
12:38 ET	222	2.75
12:39 ET	300	2.75
12:41 ET	100	2.75
12:43 ET	300	2.75
12:45 ET	169	2.75
12:48 ET	200	2.75
12:50 ET	502	2.75
12:54 ET	100	2.75
12:56 ET	500	2.755
12:57 ET	900	2.75
01:01 ET	100	2.755
01:03 ET	200	2.75
01:10 ET	100	2.75
01:14 ET	100	2.75
01:17 ET	100	2.75
01:19 ET	1133	2.75
01:24 ET	200	2.75
01:30 ET	362	2.75
01:33 ET	100	2.75
01:35 ET	3819	2.75
01:37 ET	2008	2.7377
01:39 ET	100	2.735
01:42 ET	4426	2.735
01:44 ET	350	2.73
01:46 ET	3004	2.74
01:50 ET	100	2.7439
01:51 ET	400	2.7499
01:53 ET	20021	2.74
01:55 ET	4135	2.74
01:57 ET	318	2.74
02:00 ET	100	2.735
02:02 ET	8219	2.735
02:04 ET	993	2.73
02:06 ET	16460	2.75
02:08 ET	100	2.75
02:09 ET	1534	2.75
02:11 ET	4997	2.76
02:13 ET	900	2.76
02:15 ET	300	2.755
02:18 ET	1800	2.76
02:20 ET	9713	2.77
02:22 ET	10226	2.775
02:24 ET	52479	2.785
02:26 ET	10900	2.775
02:27 ET	2600	2.775
02:29 ET	5978	2.77
02:31 ET	5667	2.78
02:33 ET	100	2.7811
02:36 ET	1000	2.7858
02:40 ET	100	2.785
02:42 ET	5368	2.785
02:44 ET	9088	2.805
02:47 ET	1219	2.8
02:49 ET	2000	2.79
02:51 ET	300	2.7918
02:54 ET	100	2.79
02:56 ET	1500	2.8
03:00 ET	4366	2.79
03:02 ET	5000	2.7901
03:03 ET	200	2.79
03:05 ET	100	2.79
03:07 ET	2403	2.78
03:09 ET	30613	2.77
03:12 ET	100	2.77
03:14 ET	2100	2.77
03:16 ET	300	2.77
03:18 ET	4471	2.77
03:20 ET	494	2.7614
03:21 ET	500	2.755
03:23 ET	200	2.75
03:25 ET	2642	2.755
03:27 ET	18323	2.775
03:30 ET	100	2.775
03:32 ET	100	2.775
03:34 ET	1243	2.765
03:38 ET	10077	2.755
03:39 ET	1080	2.75
03:41 ET	236	2.75
03:43 ET	535	2.75
03:45 ET	300	2.75
03:48 ET	800	2.7532
03:50 ET	1400	2.755
03:52 ET	1100	2.75
03:54 ET	1808	2.75
03:56 ET	5003	2.75
03:57 ET	10587	2.75
03:59 ET	13957	2.74

Data delayed at least 15 minutes.

Apr 10, 2024
- DJ Mereo BioPharma Group Price Target Maintained With a $6.00/Share by Needham, from 6:21AM ET on Wednesday Apr 10, 2024 by Dow Jones
  6:21AM ET on Wednesday Apr 10, 2024 by Dow Jones
Apr 3, 2024
- Mereo BioPharma to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference, from 7:30AM ET on Wednesday Apr 03, 2024 by Dow Jones
  7:30AM ET on Wednesday Apr 03, 2024 by Dow Jones

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesMREO Mereo BioPharma Group PLC	383.6M	-10.5x	---
United StatesHUMA Humacyte Inc	475.1M	-3.7x	---
United StatesNKTX Nkarta Inc	482.2M	-2.9x	---
United StatesCELC Celcuity Inc	484.8M	-5.9x	---
United StatesPROK ProKidney Corp	486.2M	-3.7x	---
United StatesALLO Allogene Therapeutics Inc	493.4M	-1.4x	---
As of 2024-04-28

Mereo BioPharma Group plc is a biopharmaceutical company. It is focused on the development of therapeutics for rare diseases. It has developed a portfolio of clinical-stage product candidates. The Company has two rare disease product candidates: setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat for the treatment of severe alpha-1-antitrypsin deficiency-associated lung disease (AATD-LD) and bronchiolitis obliterans syndrome (BOS). It also has two oncology product candidates in clinical development. It also includes Etigilimab, an antibody against TIGIT (T-cell immunoreceptor with Ig and ITIM domains). Its non-core partnered programme, Navicixizumab, is a bispecific antibody that inhibits delta-like ligand 4 (DLL4) and vascular endothelial growth factor (VEGF). Its non-core programs available for partnership include Acumapimod and Leflutrozole. Acumapimod is a p38 MAP kinase inhibitor therapy for treatment during severe acute exacerbations of COPD (AECOPD).

Contact Information

Headquarters: One Cavendish Place, Fourth FloorLONDON, United Kingdom W1G0QF
Phone: ---
Fax: ---

Executives

Non-Executive Independent Chairman of the Board: Michael Wyzga
Chief Executive Officer, Director: Denise Scots-Knight
Chief Financial Officer: Christine Fox
Senior Vice President - Clinical Development: Suba Krishnan
Senior Vice President - Therapeutic Head: Jackie Parkin

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$383.6M
Revenue (TTM)	$8.9M
Shares Outstanding	140.3M
Dividend Yield	0.00%
Annual Dividend Rate	---
Ex-Dividend Date	01-01-01
Pay Date	01-01-01
Beta	0.83
EPS	$-0.26
Book Value	$0.62
P/E Ratio	-10.5x
Price/Sales (TTM)	43.1
Price/Cash Flow (TTM)	---
Operating Margin	-444.28%

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Mereo BioPharma Group PLC
NASDAQ:MREOUnited States

Search Criteria

Charts

Recent News

Apr 10, 2024

DJ Mereo BioPharma Group Price Target Maintained With a $6.00/Share by Needham, from 6:21AM ET on Wednesday Apr 10, 2024 by Dow Jones

Apr 3, 2024

Mereo BioPharma to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference, from 7:30AM ET on Wednesday Apr 03, 2024 by Dow Jones

Biotechnology Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar